Host Mike Moore sits down with Shri Rhagunathan, President & CEO of Noctrix Health. Noctrix has the developed the only FDA approved device to Restless Legs Syndrome (RLS). This disease affects 1 in 10 Americans, and is the 2nd most common sleep disorder in the U.S. A limited number of pharmaceutical options currently exist to treat this disease state, all of which have a number of associated negative side effects. Their Nidra devices is a paradigm shifting breakthrough in a heavily under treated patient population.

Follow Mike Moore:

LinkedIn:   / michaeljeffreymoore  

Listen to The Bleeding Edge of Digital Health Podcast:

LinkedIn:   / thebleedingedgeofdigitalhealth  
Apple Podcasts: https://podcasts.apple.com/ph/podcast...
Spotify: https://open.spotify.com/show/23ggnkX...
Google: https://podcasts.google.com/feed/aHR0...
Amazon: https://www.amazon.com/BleedingEdge...